GLP-1 Eligibility Calculator: Do You Qualify for Ozempic or Wegovy?

Use this free GLP-1 eligibility calculator to find out whether you may qualify for medications like Ozempic, Wegovy, Mounjaro, or Zepbound. Just enter your height, weight, and age — and optionally any relevant health conditions — to get an instant eligibility estimate based on the clinical criteria doctors use.

How GLP-1 Eligibility Is Determined

The FDA approval criteria for GLP-1 weight loss medications are based on BMI, sometimes combined with weight-related health conditions. Here is how it works:

• BMI ≥ 30 (obese) — you likely qualify for all approved GLP-1 weight loss medications without needing any other conditions.
• BMI 27–29.9 (overweight) + at least one qualifying condition — you may qualify if you have Type 2 diabetes, high blood pressure, high cholesterol, sleep apnea, or cardiovascular disease.
• BMI 25–26.9 — you typically do not meet standard eligibility criteria, though a provider may consider additional factors.
• BMI below 25 — GLP-1 weight loss medications are generally not prescribed at this range.

BMI is calculated from your height and weight: BMI = weight (kg) ÷ height (m)². It is an imperfect measure — it does not account for muscle mass or body composition — but it remains the primary threshold used for GLP-1 prescribing decisions.

Which GLP-1 Medications Are Available?

Several GLP-1 and dual GIP/GLP-1 medications are currently FDA-approved for weight management or Type 2 diabetes:

• Wegovy (semaglutide 2.4mg) — FDA-approved for chronic weight management. Weekly injection. Average 15% body weight loss in clinical trials.
• Zepbound (tirzepatide) — FDA-approved for chronic weight management. Weekly injection. Highest average weight loss of any approved medication: 20–22% of body weight.
• Ozempic (semaglutide 0.5–2mg) — FDA-approved for Type 2 diabetes, widely prescribed off-label for weight. Weekly injection. Average 10–14% body weight loss.
• Mounjaro (tirzepatide) — FDA-approved for Type 2 diabetes. Same molecule as Zepbound — may have better insurance coverage for T2D patients.
• Saxenda (liraglutide 3mg) — FDA-approved for weight management. Daily injection. Older medication with average 5–8% body weight loss.

Frequently Asked Questions

Is this calculator accurate?

This calculator uses the same BMI-based criteria that doctors and clinical guidelines use to determine initial GLP-1 eligibility. However, it is an estimate — a real prescription requires a full medical evaluation by a licensed healthcare provider who will consider your complete health history, current medications, kidney and liver function, and other factors.

Do I need a diagnosis to qualify?

For the BMI ≥ 30 threshold, no additional diagnosis is required. For the BMI 27–29.9 threshold, you need at least one formally diagnosed weight-related condition. If you suspect you have one of these conditions but have not been officially diagnosed, a provider can assess this during your consultation.

Will insurance cover GLP-1 medications?

Coverage varies widely. Ozempic and Mounjaro (approved for T2D) tend to have better insurance coverage than Wegovy or Zepbound (approved for weight loss). Many plans still do not cover weight loss medications at all. Manufacturer savings cards, compounding pharmacies, and specific telehealth programs can significantly reduce out-of-pocket costs. See our complete guide to GLP-1 cost and insurance coverage.

How do I get a GLP-1 prescription?

You need a prescription from a licensed healthcare provider — a primary care physician, endocrinologist, or through a telehealth provider. Many telehealth platforms can complete an evaluation and issue a prescription within 24–48 hours. Find a GLP-1 provider here.